• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Zeltiq Aesthetics

edit

Zeltiq (pronounced Zel ′teek) Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The Zeltiq approach utilizes a patented method called Cryolipolysis™ (the use of precisely controlled cooling to remove fat) that is designed to target only fat cells and not harm the skin or other tissue.

The Zeltiq device is cleared by the FDA in the Unites States for various applications related to skin cooling during dermatologic treatments.

Recent Milestones

edit

• 
  Zeltiq Aesthetics received $25M in Series D funding. (6/3/10)
  Posted 6/3/10 at 11:10am via altassets.com
• 
  Zeltiq Aesthetics — Announced hire of new CEO - Gordie Nye (9/29/09)
  Posted 6/7/10 at 11:59am via zeltiq.com
• 
  Zeltiq Aesthetics — ZELTIQ Announces European CE Mark Approval for Non-Invasive Fat Layer Reductio (9/10/09)
  Posted 6/7/10 at 12:01pm via zeltiq.com
• 
  Zeltiq Aesthetics received $25.1M in Series C funding. (7/22/08)
  Posted 6/7/10 at 11:53am via sec.gov
• 
  Zeltiq Aesthetics received $20.3M in Series B funding. (10/29/07)
  Posted 9/15/09 at 1:59am via venturebeat.com
• 
  Zeltiq Aesthetics added Andrew Schiff as Director.
  Posted 6/3/10 at 11:11am

Videos

Screenshots

edit

Sources

1. Zeltiq raises $20.3M for fat reduction (deals.venturebeat.com) [edit]
2. SEC EDGAR database (sec.gov) [edit]
3. AltAssets (altassets.com) [edit]
Zeltiq website (zeltiq.com) [edit]
Zeltiq website (zeltiq.com) [edit]